Predicted Trait | |
Reported Trait | Prostate cancer |
Mapped Trait(s) | prostate carcinoma (EFO_0001663) |
Additional Trait Information | PheCode 185 |
Score Construction | |
PGS Name | PRSWEB_PHECODE185_GWAS-Catalog-r2019-05-03-X185_P_5e-08_MGI_20200608 |
Development Method | |
Name | GWAS Hits |
Parameters | LD Clumping (MAF >= 1%, r^2 <= 0.1) & P<=5e-08 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 117 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000118 |
Citation (link to publication) | Fritsche LG et al. Am J Hum Genet (2020) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST006085 Europe PMC: 29892016 |
140,254 individuals | European | NR |
GWAS Catalog: GCST000153 Europe PMC: 18264098 |
23,226 individuals | European | NR |
GWAS Catalog: GCST002890 Europe PMC: 25939597 |
7,541 individuals | European | NR |
GWAS Catalog: GCST001148 Europe PMC: 21743467 |
13,560 individuals | European | NR |
GWAS Catalog: GCST001147 Europe PMC: 21743057 |
7,240 individuals | European | NR |
GWAS Catalog: GCST000152 Europe PMC: 18264097 |
3,748 individuals | European | NR |
GWAS Catalog: GCST000489 Europe PMC: 19767754 |
37,350 individuals | European | NR |
GWAS Catalog: GCST003586 Europe PMC: 27262462 |
3,893 individuals | European | NR |
GWAS Catalog: GCST001719 Europe PMC: 23104005 |
59,585 individuals | European | NR |
GWAS Catalog: GCST002413 Europe PMC: 24740154 |
5,051 individuals | European | NR |
GWAS Catalog: GCST000154 Europe PMC: 18264096 |
2,329 individuals | European | NR |
GWAS Catalog: GCST001942 Europe PMC: 23535732 |
22,548 individuals | European | NR |
GWAS Catalog: GCST000017 Europe PMC: 17401363 |
2,329 individuals | European | NR |
GWAS Catalog: GCST000019 Europe PMC: 17401366 |
4,517 individuals | European | NR |
GWAS Catalog: GCST000050 Europe PMC: 17603485 |
12,791 individuals | European | NR |
GWAS Catalog: GCST007506 Europe PMC: 30410027 |
295,892 individuals | European | NR |
GWAS Catalog: GCST000307 Europe PMC: 19117981 |
2,834 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
Europe PMC: 32991828 |
[
|
European | MGI | PheCode:185; ICD9CM:185, 233.4, V10.46; ICD10CM:C61, D07.5 | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM001262 | PSS000552| European Ancestry| 5,607 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of prostate | OR: 1.756 [1.634, 1.886] β: 0.563 (0.0366) |
AUROC: 0.646 [0.627, 0.665] | Nagelkerke's Pseudo-R²: 0.0678 Brier score: 0.147 Odds Ratio (OR, top 1% vs. Rest): 3.57 [2.29, 5.57] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE185_GWAS-Catalog-r2019-05-03-X185_P_5e-08_MGI_20200608 |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000552 | PheCode:185; ICD9CM:185, 233.4, V10.46; ICD10CM:C61, D07.5 | — | [
|
— | European | — | MGI | — |